HUE047102T2 - Recombinant modified vaccinia virus ankara (mva) respiratory syncytial virus (rsv) vaccine - Google Patents

Recombinant modified vaccinia virus ankara (mva) respiratory syncytial virus (rsv) vaccine

Info

Publication number
HUE047102T2
HUE047102T2 HUE13717721A HUE13717721A HUE047102T2 HU E047102 T2 HUE047102 T2 HU E047102T2 HU E13717721 A HUE13717721 A HU E13717721A HU E13717721 A HUE13717721 A HU E13717721A HU E047102 T2 HUE047102 T2 HU E047102T2
Authority
HU
Hungary
Prior art keywords
mva
rsv
vaccine
respiratory syncytial
modified vaccinia
Prior art date
Application number
HUE13717721A
Other languages
Hungarian (hu)
Inventor
Cedric Cheminay
Robin Steigerwald
Paul Chaplin
Original Assignee
Bavarian Nordic As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bavarian Nordic As filed Critical Bavarian Nordic As
Publication of HUE047102T2 publication Critical patent/HUE047102T2/en

Links

HUE13717721A 2012-08-01 2013-03-15 Recombinant modified vaccinia virus ankara (mva) respiratory syncytial virus (rsv) vaccine HUE047102T2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261678367P 2012-08-01 2012-08-01
EP12005594 2012-08-01

Publications (1)

Publication Number Publication Date
HUE047102T2 true HUE047102T2 (en) 2020-04-28

Family

ID=66440168

Family Applications (1)

Application Number Title Priority Date Filing Date
HUE13717721A HUE047102T2 (en) 2012-08-01 2013-03-15 Recombinant modified vaccinia virus ankara (mva) respiratory syncytial virus (rsv) vaccine

Country Status (8)

Country Link
JP (2) JP6895944B2 (en)
DK (1) DK2879702T3 (en)
ES (1) ES2767324T3 (en)
HU (1) HUE047102T2 (en)
LT (1) LT2879702T (en)
PT (1) PT2879702T (en)
UA (1) UA123385C2 (en)
ZA (1) ZA201500606B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2767324T3 (en) * 2012-08-01 2020-06-17 Bavarian Nordic As Recombinant Ankara modified vaccinia virus (MVA) vaccine for respiratory syncytial virus (RSV)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010522540A (en) * 2007-03-21 2010-07-08 アイディー バイオメディカル コーポレイション オブ ケベック Chimeric antigen
US8846056B2 (en) * 2009-08-04 2014-09-30 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, Centers For Disease Control Anti-RSV immunogens and methods of immunization
EP2627774B1 (en) 2010-10-15 2018-11-21 Bavarian Nordic A/S Recombinant modified vaccinia virus ankara (mva) influenza vaccine
WO2012085936A2 (en) * 2010-12-20 2012-06-28 Panacea Biotech Ltd Recombinant respiratory syncytial virus plasmids and vaccines
WO2012089231A1 (en) * 2010-12-30 2012-07-05 Okairòs Ag Paramyxovirus vaccines
JP6523955B2 (en) 2012-08-01 2019-06-05 バヴァリアン・ノルディック・アクティーゼルスカブ Recombinant modified vaccinia virus Ankara (MVA) RS virus (RSV) vaccine
ES2767324T3 (en) 2012-08-01 2020-06-17 Bavarian Nordic As Recombinant Ankara modified vaccinia virus (MVA) vaccine for respiratory syncytial virus (RSV)

Also Published As

Publication number Publication date
JP2019068833A (en) 2019-05-09
ES2767324T3 (en) 2020-06-17
JP6895944B2 (en) 2021-06-30
JP2021137023A (en) 2021-09-16
JP7317896B2 (en) 2023-07-31
DK2879702T3 (en) 2020-02-24
PT2879702T (en) 2020-02-04
UA123385C2 (en) 2021-03-31
ZA201500606B (en) 2020-05-27
LT2879702T (en) 2020-02-10

Similar Documents

Publication Publication Date Title
HK1205459A1 (en) Recombinant modified vaccinia virus ankara (mva) respiratory syncytial virus (rsv) vaccine (mva)(rsv)
SG10201801431TA (en) Respiratory syncytial virus (rsv) vaccine
HK1222125A1 (en) Recombinant nanoparticle rsv f vaccine for respiratory syncytial virus rsv f
IL258831A (en) Respiratory syncytial virus vaccine
HK1209646A1 (en) Nasal influenza vaccine composition
AP2014007994A0 (en) Vaccine against rsv
EP2806891A4 (en) Parainfluenza virus 5 based vaccines
EP2432503A4 (en) Universal influenza vaccine based on recombinant modified vaccinia ankara virus (mva)
EP2631290A4 (en) Virus vector for prime/boost vaccines, which comprises vaccinia virus vector and sendai virus vector
EP2940134A4 (en) Vaccine prepared utilizing human parainfluenza virus type 2 vector
HK1223644A1 (en) Semi-live respiratory syncytial virus vaccine
HK1223643A1 (en) Semi-live respiratory syncytial virus vaccine
EP2929893A4 (en) Adjuvant for mucous membrane vaccine
EP3046578A4 (en) Recombinant respiratory syncytial virus (rsv) and vaccines
ZA201405107B (en) Mtb-c vaccine against asthma
EP2839840A4 (en) Recombinant trivalent vaccine against human influenza
ZA201500606B (en) Recombinant modified vaccinia virus ankara (mva) respiratory syncytial virus (rsv) vaccine
HK1206272A1 (en) Vaccine against rsv rsv